Inogen | INGN - 税前利润





税前利润 更改 日
Abbott USD 2.36B 178M 2025-12
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -6.4M 5.03M 2025-09
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 2.36M 2.45M 2025-12
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 938M 3M 2025-09
Chart Industries USD -182.7M 278.1M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 300M 58.9M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Orthofix International USD -2.19M 20.07M 2025-12
Philips EUR 275M 62M 2025-09
ResMed USD 482.38M 2.51M 2025-09
Steris USD 324.4M 92.5M 2025-09
Stryker USD 1.03B 13M 2025-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
X T L Biopharmaceuticals USD -385K 168K 2024-12
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09